Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Blood ; 97(4): 1043-9, 2001 Feb 15.
Artículo en Inglés | MEDLINE | ID: mdl-11159535

RESUMEN

Following stress signals, the p53 tumor suppressor protein plays a critical role in regulation of cell proliferation, mainly through induction of growth arrest or apoptosis. Therefore, this protein needs to be strictly regulated and numerous studies have shown that the MDM2 protein is an essential element for p53 regulation in normal cells and, most importantly, that overexpression of MDM2 is responsible for p53 inactivation in various types of tumors. A previous study showed that this is the case in some Burkitt lymphoma (BL) cell lines, where enhanced translation of mdm2 messenger RNA results in overexpression of the protein that complexes and inactivates wild-type p53. To further investigate the role of the p53/MDM2 complex in these BL cells, as well as in other lymphoid cells that do not overexpress MDM2, this study used antisense oligodeoxynucleotides directed either against mdm2 or against p53. Results show that the mdm2 antisense oligodeoxynucleotide induces apoptosis of cells that express a high or low level of MDM2 protein, only if they contain wild-type p53. Moreover, apoptosis is independent of the accumulation of p53 following mdm2 antisense treatment. Finally, the p53 antisense oligodeoxynucleotide, which inhibits the expression of wild-type p53, also induces a decrease of the MDM2 level in cells, whether or not they overexpress this protein, and causes apoptosis of these cells. These results indicate that decreasing the MDM2 protein level by directly or indirectly targeting its biosynthesis is a potent tool for the induction of apoptosis.


Asunto(s)
Apoptosis/fisiología , Linfoma de Burkitt/patología , Genes p53 , Linfocitos/citología , Proteínas de Neoplasias/fisiología , Células Madre Neoplásicas/citología , Proteínas Nucleares , Oligodesoxirribonucleótidos Antisentido/farmacología , Proteínas Proto-Oncogénicas/fisiología , Proteína p53 Supresora de Tumor/fisiología , Linfoma de Burkitt/genética , Depresión Química , Regulación de la Expresión Génica/efectos de los fármacos , Humanos , Proteínas de Neoplasias/biosíntesis , Proteínas de Neoplasias/deficiencia , Proteínas de Neoplasias/genética , Proteínas Proto-Oncogénicas/biosíntesis , Proteínas Proto-Oncogénicas/deficiencia , Proteínas Proto-Oncogénicas/genética , Proteínas Proto-Oncogénicas c-mdm2 , Transducción de Señal , Células Tumorales Cultivadas/citología , Proteína p53 Supresora de Tumor/biosíntesis , Proteína p53 Supresora de Tumor/deficiencia , Proteína p53 Supresora de Tumor/genética
2.
J Biol Chem ; 275(22): 16723-9, 2000 Jun 02.
Artículo en Inglés | MEDLINE | ID: mdl-10747952

RESUMEN

The molecular genetic basis of the P histo-blood group system has eluded characterization despite extensive studies of the biosynthesis of the P(1), P, and P(k) glycolipids. The main controversy has been whether a single or two distinct UDP-Gal:Galbeta1-R 4-alpha-galactosyltransferases catalyze the syntheses of the structurally related P(1) and P(k) antigens. The P(1) polymorphism is linked to 22q11.3-ter. Data base searches with the coding region of an alpha4GlcNAc-transferase identified a novel homologous gene at 22q13.2 designated alpha4Gal-T1. Expression of full coding constructs of alpha4Gal-T1 in insect cells revealed it encoded P(k) but not P(1) synthase activity. Northern analysis showed expression of the transcript correlating with P(k) synthase activity and antigen expression in human B cell lines. Transfection of P(k)-negative Namalwa cells with alpha4Gal-T1 resulted in strong P(k) expression. A single homozygous missense mutation, M183K, was found in six Swedish individuals of the rare p phenotype, confirming that alpha4Gal-T1 represented the P(k) gene. Sequence analysis of the coding region of alpha4Gal-T1 in P(1)+/- individuals did not reveal polymorphisms correlating with P(1)P(2) typing.


Asunto(s)
Galactosiltransferasas/genética , Sistema del Grupo Sanguíneo P/genética , Secuencia de Aminoácidos , Secuencia de Bases , Secuencia de Carbohidratos , Mapeo Cromosómico , Cromosomas Humanos Par 22 , Clonación Molecular , Galactosiltransferasas/química , Homocigoto , Humanos , Datos de Secuencia Molecular , Mutación Missense , Fenotipo , Polimorfismo Genético , Homología de Secuencia de Aminoácido
3.
Blood ; 90(7): 2757-67, 1997 Oct 01.
Artículo en Inglés | MEDLINE | ID: mdl-9326243

RESUMEN

In the hematopoietic system CD77, a glycolipid surface antigen, is restricted to group I Burkitt's lymphoma (BL) cell lines and a subset of germinal center B lymphocytes. Recently, we have reported that recombinant B subunits of Verotoxin, which specifically binds to CD77, induce programmed cell death of CD77+ BL cells. Here, we show that an anti-CD77 monoclonal antibody (38.13) immobilized on tissue culture dishes also induces apoptosis, and we have explored the signal transducing events leading to this cell death. We show that ligation of CD77 antigen causes an increase of the intracellular Ca2+ concentration owing to an influx of extracellular Ca2+ through calcium channels. Chelation of extracellular Ca2+ with EGTA partially prevents anti-CD77-induced apoptosis, indicating that this process is probably Ca2+ dependent. We show that the cross-linking of CD77 provokes an increase of intracellular cAMP levels followed by cAMP-dependent protein kinase activation. We report that BL cells produce ceramide when they are exposed to 38.13 but, unexpectedly, without a concomitant decrease in sphingomyelin or CD77 content. Finally, we provide evidence that C2-ceramide, calcium ionophore, and forskolin (which increases intracellular levels of cAMP) independently induce apoptosis of CD77+ BL cells and, moreover, that C2-ceramide and forskolin strongly synergize to cause cell death. The possible role of CD77-mediated apoptosis in the B cell selection that occurs in germinal centers is discussed.


Asunto(s)
Apoptosis/fisiología , Linfoma de Burkitt/patología , Transducción de Señal , Trihexosilceramidas/fisiología , Calcio/metabolismo , Canales de Calcio/metabolismo , Ceramidas/biosíntesis , Quelantes/farmacología , Colforsina/farmacología , AMP Cíclico/biosíntesis , Ácido Egtácico/farmacología , Humanos , Transporte Iónico , Ionóforos/farmacología , Células Tumorales Cultivadas
4.
Biochem Biophys Res Commun ; 229(1): 27-35, 1996 Dec 04.
Artículo en Inglés | MEDLINE | ID: mdl-8954079

RESUMEN

Fas (Apo1/CD95) is a member of the tumour necrosis factor/nerve growth factor receptor superfamily and mediates apoptosis in various cell types (for review sec [1]). Although this apoptotic activity has been clearly related to homeostasis in the immune system and pathological situations in non-lymphoid organs, the Fas signaling pathway remains mostly elusive. We and others previously showed that Fas-induced apoptosis of primary culture hepatocytes requires either an inhibitor of translation or a protein kinase inhibitor, suggesting that two distinct pathways of Fas signaling exist in hepatocytes. We report here that activation of ICE-like and CPP32-like cysteine proteases are required for Fas-mediated apoptosis, but that these pathways involve different subclasses of serine proteases and are selectively modulated by inhibitors of protein tyrosine kinases. These results confirm that distinct pathways can lead to Fas-induced apoptosis in hepatocytes. Further understanding of these pathways could facilitate the rational design of anti-apoptotic drugs in liver diseases associated with massive Fas-mediated hepatocyte apoptosis, including fulminant hepatitis.


Asunto(s)
Apoptosis , Caspasas , Hígado/fisiología , Receptor fas/metabolismo , 1-(5-Isoquinolinesulfonil)-2-Metilpiperazina/farmacología , Animales , Caspasa 1 , Caspasa 3 , Células Cultivadas , Ceramidas/metabolismo , Cicloheximida/farmacología , Cisteína Endopeptidasas/metabolismo , Inducción Enzimática , Inhibidores Enzimáticos/farmacología , Hígado/citología , Ratones , Fosfoproteínas Fosfatasas/antagonistas & inhibidores , Inhibidores de Proteínas Quinasas , Inhibidores de Serina Proteinasa/farmacología , Transducción de Señal , Esfingomielinas/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...